PolyPid's Innovations in Drug Delivery and Surgical Outcomes

Author: Owen Jenkins Updated: 09-02-2025 08:36 AM

PolyPid's Role in Transforming Surgical Care

PolyPid Ltd. (NASDAQ: PYPD) is paving the way for advancements in surgical outcomes through innovative drug delivery systems. This late-stage biopharma company focuses on enhancing surgical recovery and minimizing complications related to surgical interventions.

Presentation at the Israel Controlled Release Society Conference

Dalit Hazan, Deputy CEO and EVP of Research & Development, will present at the 14th meeting of the Israel Controlled Release Society (ICRS) Conference. This significant event, set to occur at the Enjoy Hotel near the Dead Sea, highlights groundbreaking research in drug delivery technologies.

Details of the Presentation

Hazan's presentation, titled "Novel Local Prolonged Drug Delivery: From Platform Idea to a Successful Phase III Trial," takes place on September 7. This session will showcase advances in targeted drug delivery, crucial for improving patient outcomes.

Innovative Drug Delivery Technology

At the heart of PolyPid’s innovations is their proprietary PLEX technology, which stands for Polymer-Lipid Encapsulation matriX. This platform allows for precise and controlled delivery of active pharmaceutical ingredients (APIs), enabling effective therapeutic administration that can last from days to months.

Successful Phase III Trials

The results from the recent Phase III trials of D-PLEX???, PolyPid's flagship product aimed at preventing surgical site infections post-abdominal colorectal surgery, have been promising. These successful outcomes have set the stage for the upcoming New Drug Application (NDA) submission expected early next year.

Future Directions of PolyPid

With a robust pipeline of innovative therapies targeting oncology, obesity, and diabetes, PolyPid is well-positioned for future growth and impact on patient care. Their ongoing research and commitment to improving surgical outcomes through technology continue to attract attention and support from the medical community.

Engaging with the Community

For those interested in learning more about the company's activities and advancements, PolyPid encourages visitors to explore their website for insights and developments in their therapeutic approaches.

Contact Information

For inquiries, you can reach out to:

PolyPid Ltd.
Ori Warshavsky
908-858-5995
IR@Polypid.com

Investor & IR
Arx | Capital Markets
North American Equities Desk
polypid@arxadvisory.com

Frequently Asked Questions

What is PolyPid focusing on in their research?

PolyPid is focused on enhancing surgical outcomes through innovative drug delivery systems, particularly for preventing surgical site infections.

When and where is the ICRS Conference?

The ICRS Conference will take place from September 7-9 at the Enjoy Hotel near the Dead Sea.

What is the significance of the PLEX technology?

PLEX technology enables controlled and prolonged release of therapeutic agents, improving the effectiveness of treatments administered during surgical procedures.

What is D-PLEX????

D-PLEX??? is PolyPid's lead product candidate designed to prevent surgical site infections in patients undergoing colorectal surgery.

How can I contact PolyPid for more information?

You can contact PolyPid directly via email at IR@Polypid.com for inquiries.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.